CD14 and liver cancer: TGR5 receptors have many different agonists, but DCA and LCA are effective components that are able to inhibit tumor necrosis factor-α production in CD14+ macrophages by increasing the cAMP content to regulate NF-κB-p65 activation in the macrophages of liver cancer cells [22].